Manon Allaire

16PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Work integrated learning (incl. internships)HaematologyCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 20, 2026
Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

|Mar 19, 2026
Preparedness and performance in pediatric assessment: linking OSCE, written exams, and training exposure in a two-year comparative study of medical students.

Anaïs Lemoine, Nada Sabourdin, Maxens Decavèle

|Sep 24, 2025
Early Hemostatic Treatment Could Improve 30-Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma.

Apolline Commin, Chloé Metivier, Manon Allaire

|Sep 04, 2025
Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort.

Manon Allaire, Elhadji Malick Thiam, Guiliana Amaddeo

|Aug 12, 2025
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy.

Marta Fortuny, Leonardo G da Fonseca, Manon Allaire

|Mar 05, 2025
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.

Beat Moeckli, Charles-Henri Wassmer, Sofia El Hajji

Pageof 3

Frequent Collaborators

4 joint publications

Jean-Charles Nault

4 joint publications

Dominique Thabut

2 joint publications

Claudia Campani

2 joint publications

Fabio Marra